Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 3—March 2024
Research

Estimates of Incidence and Predictors of Fatiguing Illness after SARS-CoV-2 Infection

Quan M. VuComments to Author , Annette L. Fitzpatrick, Jennifer R. Cope, Jeanne Bertolli, Nona Sotoodehnia, T. Eoin West, Nikki Gentile, and Elizabeth R. Unger
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (Q.M. Vu, J.R. Cope, J. Bertolli, E.R. Unger); University of Washington, Seattle, Washington, USA (A.L. Fitzpatrick, N. Sotoodehnia, T.E. West, N. Gentile)

Main Article

Figure 2

Cumulative incidence of fatigue (A) and chronic fatigue (B) among 4,589 COVID-19 cases and 9,022 non–COVID-19 controls in study of fatiguing illness after SARS-CoV-2 infection, Washington, USA, February 2020–February 2021. Shading around data lines indicates 95% CIs.

Figure 2. Cumulative incidence of fatigue (A) and chronic fatigue (B) among 4,589 COVID-19 cases and 9,022 non–COVID-19 controls in study of fatiguing illness after SARS-CoV-2 infection, Washington, USA, February 2020–February 2021. Shading around data lines indicates 95% CIs.

Main Article

Page created: January 15, 2024
Page updated: February 22, 2024
Page reviewed: February 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external